Fingerprint
Dive into the research topics of 'Phase II trial of gemcitabine in refractory or relapsed small-cell lung cancer: Eastern Cooperative Oncology Group Trial 1597'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Phase II trial of gemcitabine in refractory or relapsed small-cell lung cancer: Eastern Cooperative Oncology Group Trial 1597
Gregory A. Masters, Lieven Declerck, Charles Blanke, Alan Sandler, Russell DeVore, Kathy Miller, David Johnson
Research output: Contribution to journal › Article › peer-review
112
Scopus
citations